FGF19 and hepatocellular carcinoma: The frequency of CTNNB1 (WNT/β-catenin) and TP53 mutations significantly increased in those with advanced tumors, while amplification of the FGF19/CNND1 locus was mainly observed in those with HCC with poor prognosis [21,24,25].